Business
Issue of options and directors dealings
Issue of options and directors dealings.
About this update from Valirx Plc
[{"type":"text","content":"\n \nRNS Number : 4699E ValiRx PLC 09 February 2018 \n\n \n \n \nVALIRX PLC\n(\"ValiRx\", the \"Company\" or the \"Group\")\n \nIssue of options and directors dealings\n \nLondon, UK., 9 February 2018: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, announces it has awarded options to directors and key management. The options may be exercised at a price of 4 pence per share at any time up until 7 February 2028.\n \n\n\n\n\nName of Director\n\n\nNumber of Existing Options*\n\n\nOption Award\n\n\nTotal number of Options\n\n\n% of existing share capital\n\n\n\n\nOliver de Giorgio-Miller\n\n\n555,000\n\n\n2,750,000\n\n\n3,305,000\n\n\n0.8%\n\n\n\n\nDr Satu Vainikka\n\n\n694,000\n\n\n3,625,000\n\n\n4,319,000\n\n\n1.1%\n\n\n\n\nDr George Morris\n\n\n597,000\n\n\n3,125,000\n\n\n3,722,000\n\n\n0.9%\n\n\n\n\nGerry Desler\n\n\n592,960\n\n\n3,000,000\n\n\n3,592,960\n\n\n0.9%\n\n\n\n\nKevin Alexander\n\n\n545,000\n\n\n2,500,000\n\n\n3,045,000\n\n\n0.7%\n\n\n\n\nOthers\n\n\n429,000\n\n\n2,300,000\n\n\n2,279,000\n\n\n0.6%\n\n\n\n\nTotal\n\n\n3,412,960\n\n\n17,300,000\n\n\n20,712,960\n\n\n5.0%\n\n\n\n\n*existing options are exercisable at a price between 43.125p - 125p\nThe issued share capital of the Company comprises 407,462,717 ordinary shares of 0.1 pence per shares. The table below illustrates the existing equity holdings of the directors:\n\n\n\n\nName of Director\n\n\nTotal number of shares\n\n\n% of existing share capital\n\n\n\n\nOliver de Giorgio-Miller\n\n\n59,555\n\n\n0.015%\n\n\n\n\nDr Satu Vainikka\n\n\n624,909\n\n\n0.15%\n\n\n\n\nDr George Morris\n\n\n588,287\n\n\n0.14%\n\n\n\n\nGerry Desler\n\n\n541,875\n\n\n0.13%\n\n\n\n\nKevin Alexander\n\n\n104,278\n\n\n0.026%\n\n\n\n\nTotal\n\n\n1,918,904\n\n\n0.46%\n\n\n\n\n \n \n*** ENDS ***\n \nFor more information, please contact:\n \n\n\n\n\nValiRx plc\n\n\nTel: +44 (0) 20 3008 4416\nwww.valirx.com\n\n\n\n\nDr Satu Vainikka, Chief Executive\n\n\nTel: +44 (0) 20 3008 4416\n\n\n\n\nTarquin Edwards, Head of Communications.\n\n\nTel: +44 (0) 7879 458 364\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n\nCairn Financial Advisers LLP (Nominated Adviser) \nLiam Murray/Jo Turner/Richard Nash\n\n\nTel: +44 (0) 20 7213 0880\n\n\n\n\n\n\n\n\n\n\n\n\nBeaufort Securities Limited (Broker) \nJon Belliss\n\n\nTel: +44 (0...